ABMD - Abiomed, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2020)Next Year (2021)
No. of Analysts9999
Avg. Estimate0.9714.515.82
Low Estimate0.890.964.325.16
High Estimate1.121.134.96.4
Year Ago EPS1.951.095.14.51
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2020)Next Year (2021)
No. of Analysts8899
Avg. Estimate210.69M214.73M927.1M1.15B
Low Estimate210.08M210.99M919.8M1.1B
High Estimate211.6M217.5M943.41M1.23B
Year Ago Sales180.01MN/A769.43M927.1M
Sales Growth (year/est)17.00%N/A20.50%24.10%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.0.820.740.941.08
EPS Actual1.951.090.971.09
Difference1.130.350.030.01
Surprise %137.80%47.30%3.20%0.90%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2020)Next Year (2021)
Current Estimate0.9714.515.82
7 Days Ago1.0214.545.86
30 Days Ago1.0214.545.86
60 Days Ago1.121.094.946.58
90 Days Ago1.121.094.966.63
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/A1N/AN/A
Up Last 30 DaysN/A1N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A11
Growth EstimatesABMDIndustrySectorS&P 500
Current Qtr.-50.30%N/AN/A0.02
Next Qtr.-8.30%N/AN/A0.03
Current Year-11.60%N/AN/A0.05
Next Year29.00%N/AN/A0.10
Next 5 Years (per annum)28.50%N/AN/A0.09
Past 5 Years (per annum)66.13%N/AN/AN/A